- Beat earnings estimates in all of the last 4 quarters
- Excellent financial health (Piotroski 8/9)
- Strong return on equity of 39.0%
Stronger technical forecast for Bristol-Myers Squibb stock price after Monday trading
(Updated on Jul 13, 2026)
The Bristol-Myers Squibb stock price gained 3.06% on the last trading day (Monday, 13th Jul 2026), rising from $57.58 to $59.34. During the last trading day the stock fluctuated 3.30% from a day low at $57.54 to a day high of $59.44. The price has been going up and down for this period, and there has been a 3.16% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 821 thousand more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $713.45 million.
Given the current short-term trend, the stock is expected to fall -3.18% during the next 3 months and, with a 90% probability hold a price between $51.82 and $57.45 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
BMY Signals & Forecast
Mostly positive signals in the chart today. The Bristol-Myers Squibb stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $57.89 and $56.74. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 9.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star 12 Months
The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Bristol-Myers Squibb stock
Bristol-Myers Squibb finds support from accumulated volume at $57.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.90 (3.30%) between high and low. For the last week, the stock has had daily average volatility of 1.96%.
Our recommended stop-loss: $56.56 (-4.69%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 15 days ago.)
Trading Expectations (BMY) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Bristol-Myers Squibb Company to open at $58.77, and during the day (based on 14 day Average True Range), to move between $58.64 and $60.04, which gives a possible trading interval of +/-$1.41 (+/-2.40%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 2.40% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $59.39 (0.08%) than the support at $57.52 (3.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Bristol-Myers Squibb Company stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
3.664
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $58.77 ( 0.95%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BMY Performance
Trading levels for BMY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 60.67 | 2.25% |
| R2 | 59.95 | 1.02% |
| R1 | 59.50 | 0.268% |
| Price | 59.34 | |
| S1 | 58.05 | -2.18% |
| S2 | 57.60 | -2.93% |
| S3 | 56.87 | -4.16% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 60.59 | 2.11% |
| R2 | 60.17 | 1.40% |
| R1 | 59.39 | 0.0843% |
| Price | 59.34 | |
| S1 | 57.52 | -3.07% |
| S2 | 54.95 | -7.40% |
| S3 | 54.00 | -9.00% |
BMY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 02, 2026 | Jul 02, 2026 | Aug 03, 2026 | $0.630 | 1.17% |
| 2 | Mar 02, 2026 | Apr 02, 2026 | May 01, 2026 | $0.630 | 1.01% |
| 3 | Jan 02, 2026 | Jan 02, 2026 | Feb 02, 2026 | $0.630 | 1.20% |
| 4 | Sep 17, 2025 | Oct 03, 2025 | Nov 03, 2025 | $0.620 | 1.38% |
| 5 | Jun 17, 2025 | Jul 03, 2025 | Aug 01, 2025 | $0.620 | 1.33% |
FAQ
Click here for our free guide on how to buy Bristol-Myers Squibb Stock.
Buy BMY